Literature DB >> 18613032

Src transformation of colonic epithelial cells: enhanced anchorage-independent growth in an Apc(+/min) background.

Sabata S Constancio-Lund1, Jan Brabek, Steven K Hanks.   

Abstract

Colon cancer arises through a multistep process involving inactivation of tumor suppressor proteins and activation of oncogene-encoded proteins. Development of colon cancer frequently involves mutation of the adenomatous polyposis coli (APC) tumor suppressor. The activity of the proto-oncogene-encoded Src tyrosine kinase is commonly elevated in colon cancer, with higher activity observed as tumors progress and metastasize. Both APC and Src are multifunctional proteins that have been implicated in the control of cell proliferation, but also as regulators of cytoskeletal changes associated with cell motility and invasion. To investigate the potential for biological cooperativity between APC partial loss-of-function and Src gain-of-function, oncogenic Src was stably expressed in mouse colon epithelial cell lines IMCE (APC(+/min)) and YAMC (APC(+/+)). Under permissive growth conditions, these lines are conditionally immortalized through inactivation of p53. Irrespective of the APC genotype or p53 status, oncogenic Src expression led to morphologic transformation associated with loss of cell-cell junctions, cytoskeletal disorganization, and acquisition of invasive properties. However IMCE cells that carry one copy of the mutant APC(min) allele exhibited increased capacity for Src-mediated anchorage-independent proliferation as compared to the YAMC cells, and this property was enhanced under permissive growth conditions. beta-catenin levels and transcriptional activity were also elevated in the Src-transformed IMCE cells. The selective Src inhibitor, AZD0530, was found to be effective in blocking both cell invasion and anchorage-independent proliferation. These findings suggest that the combined effects of elevated Src activity and APC partial loss-of-function may contribute to the growth of colon tumors. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 18613032      PMCID: PMC2644448          DOI: 10.1002/mc.20466

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  42 in total

1.  Differential requirements of the MAP kinase and PI3 kinase signaling pathways in Src- versus insulin and IGF-1 receptors-induced growth and transformation of rat intestinal epithelial cells.

Authors:  K T Nguyen; W J Wang; J L Chan; L H Wang
Journal:  Oncogene       Date:  2000-11-09       Impact factor: 9.867

2.  Invadopodia: unique methods for measurement of extracellular matrix degradation in vitro.

Authors:  E T Bowden; P J Coopman; S C Mueller
Journal:  Methods Cell Biol       Date:  2001       Impact factor: 1.441

3.  Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells.

Authors:  Rosalyn B Irby; Timothy J Yeatman
Journal:  Cancer Res       Date:  2002-05-01       Impact factor: 12.701

4.  Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition.

Authors:  Egle Avizienyte; Margaret C Frame
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

Review 5.  Treatment for advanced tumors: SRC reclaims center stage.

Authors:  Justin M Summy; Gary E Gallick
Journal:  Clin Cancer Res       Date:  2006-03-01       Impact factor: 12.531

6.  Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis.

Authors:  Heike Aligayer; Douglas D Boyd; Markus M Heiss; Eddie K Abdalla; Steven A Curley; Gary E Gallick
Journal:  Cancer       Date:  2002-01-15       Impact factor: 6.860

Review 7.  APC, signal transduction and genetic instability in colorectal cancer.

Authors:  R Fodde; R Smits; H Clevers
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

8.  Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.

Authors:  Y Tokumitsu; S Nakano; H Ueno; Y Niho
Journal:  J Cell Physiol       Date:  2000-05       Impact factor: 6.384

9.  APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits".

Authors:  A J Rowan; H Lamlum; M Ilyas; J Wheeler; J Straub; A Papadopoulou; D Bicknell; W F Bodmer; I P Tomlinson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

10.  Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements.

Authors:  Michael T Veeman; Diane C Slusarski; Ajamete Kaykas; Sarah Hallagan Louie; Randall T Moon
Journal:  Curr Biol       Date:  2003-04-15       Impact factor: 10.834

View more
  3 in total

1.  Prediction and testing of biological networks underlying intestinal cancer.

Authors:  Vishal N Patel; Gurkan Bebek; John M Mariadason; Donghai Wang; Leonard H Augenlicht; Mark R Chance
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

2.  CSK-homologous kinase (CHK/MATK) is a potential colorectal cancer tumour suppressor gene epigenetically silenced by promoter methylation.

Authors:  Anderly C Chüeh; Gahana Advani; Momeneh Foroutan; Jai Smith; Nadia Ng; Harshal Nandurkar; Daisy S Lio; Hong-Jian Zhu; Yuh-Ping Chong; Heather Verkade; Donald J Fujita; Jeffrey Bjorge; Faiza Basheer; Jet Phey Lim; Ian Luk; Amardeep Dhillon; Anuratha Sakthianandeswaren; Dmitri Mouradov; Oliver Sieber; Frédéric Hollande; John M Mariadason; Heung-Chin Cheng
Journal:  Oncogene       Date:  2021-03-25       Impact factor: 9.867

3.  Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.

Authors:  Saad Yousuf; MeiLi Duan; Erika L Moen; Sam Cross-Knorr; Kate Brilliant; Benjamin Bonavida; Theresa LaValle; Kam C Yeung; Fahd Al-Mulla; Eugene Chin; Devasis Chatterjee
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.